C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2002
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002	US20020173524 Modulation of CCR4 function
11/21/2002	US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002	CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002	EP1257550A1 Platelet adp receptor inhibitors
11/20/2002	EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/19/2002	US6482958 Methods for the preparation of 4-hydroxy benzothiophene
11/19/2002	US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482774 Substituted (4-brompyrazole-3-yl) benzazoles
11/19/2002	US6482773 Pyridazin-3-one derivatives, their use, and intermediates for their production
11/18/2002	WO2001087878A1 Novel benzothiophene derivatives
11/18/2002	WO2001087855A1 Triazole derivatives
11/18/2002	CA2409821A1 Novel benzothiophene derivatives
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090335A1 Azole compounds, process for preparation of the same and use thereof
11/14/2002	WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002089810A1 Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002089799A2 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/14/2002	WO2002089782A2 Dioxanes and uses thereof
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002	WO2002068417A3 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/14/2002	WO2002055014A3 Therapeutic chroman compounds
11/14/2002	WO2002055013A3 Therapeutic chromone compounds
11/14/2002	WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002	US20020169325 Useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia, atherosclerosis, gastrointestinal disorders
11/14/2002	US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002	US20020169191 Oxazolidinone compounds and methods of preparation and use thereof
11/14/2002	US20020169188 Modulating neurotransmission in the central nervous system
11/14/2002	US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002	US20020169166 Benzimidazoles that are useful in treating sexual dysfunction
11/14/2002	US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002	US20020169160 Sulfonamide matrix metalloproteinase inhibitors
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	US20020168358 Modulating the binding of the particular chemokines SLC (secondary lymphoid chemokine), and MIP-3b (macrophage inflammatory protein-3b), to immune system T-cells and dendritic cells to treat adverse inflammatory responses etc
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446387A1 Azole compound, process for producing the same and use thereof
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/13/2002	EP1256578A1 Thiazole derivatives and their use as cdk inhibitors
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002	EP1012139B1 Azetidinone derivatives as beta-lactamase inhibitors
11/13/2002	EP0891340B1 Oxazole derivatives, their production and use
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379774A Compounds
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/12/2002	WO2001087863A1 3-arylisothiazoles and their use as herbicides
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002	CA2408686A1 3-arylisothiazoles and their use as herbicides
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/11/2002	CA2385692A1 Thiazole derivatives
11/07/2002	WO2002088116A1 Coumarin derivative
11/07/2002	WO2002088112A1 Heterocyclic compound and antitumor agent containing the same as active ingredient
11/07/2002	WO2002088111A1 Novel benzylpiperidine compound
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088099A1 Thiazolylcinnamonitrile compound and pest control agent
11/07/2002	WO2002088098A1 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088093A1 Benzimidazoles that are useful in treating sexual dysfunction
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088087A1 Novel heterocyclic derivatives
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4

1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 628